Gardasil's approval has been broadened by the FDA to include an indication for boys and young men ages 9 through 26 for prevention of genital warts caused by HPV types 6 and 11. "But approximately 25 percent of cervical cancers are caused by other cancer-causing HPV types. According to GlaxoSmithKline, the vaccine is 70 percent effective against pre-cancerous lesions, regardless of HPV type. Gardasil, for girls and women ages 9 to 26, prevents against cervical, vulvar and vaginal cancers and protects against HPV types 11, 16 and 18. Cervarix, manufactured by GlaxoSmithKline, was approved Friday for prevention of cervical cancer and pre-cancerous lesions caused by human papillomavirus (HPV) types 16 and 18.